Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Age plays a more important role than genetics in affecting gene expression profiles as we get older

Amid much speculation and research about how our genetics affect the way we age, a University of California, Berkeley, study now shows that individual differences in our DNA matter less as we get older and become prone to diseases of aging, such as diabetes and cancer.

7 Oct 2022

New biosensing technology for detecting Alzheimer’s disease in the blood

Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer's disease, from biomarkers in blood samples.

7 Oct 2022

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

A recent study assesses the neuroprotective potential of the active constituents of cannabis in treating dementia and Alzheimer's disease.

6 Oct 2022

Omega-3 levels could play a role in improving cognitive resilience in middle-aged people

An exploratory study suggests that people who eat more foods with omega-3 fatty acids in midlife may have better thinking skills and even better brain structure than people who eat few foods with the fatty acids.

5 Oct 2022

Consuming more omega-3s associated with better brain health and cognition in middle age

Eating cold-water fish and other sources of omega-3 fatty acids may preserve brain health and enhance cognition in middle age, new evidence indicates.

5 Oct 2022

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

New research from the University of Cincinnati bolsters a hypothesis that Alzheimer's disease is caused by a decline in levels of a specific protein, contrary to a prevailing theory that has been recently called into question.

5 Oct 2022

Newly identified mechanism may explain why women are more vulnerable to Alzheimer's disease

Case Western Reserve University researchers have identified a mechanism in brain tissue that may explain why women are more vulnerable to Alzheimer's disease - a finding that they say could help lead to new medicines to treat the disease.

4 Oct 2022

Viagra and Cialis may not be suitable candidates for treating dementia, NIH DREAM study shows

Results from the National Institutes of Health's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study show that sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for treating dementia.

4 Oct 2022

Stanford researchers discover a sustainable way to produce cancer-fighting compound in the lab

Stanford University researchers have discovered a rapid and sustainable way to synthetically produce a promising cancer-fighting compound right in the lab.

3 Oct 2022

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

Despite constituting the largest minority group in the U.S. and expressing interest in participating in clinical trials, people with disabilities remain excluded.

3 Oct 2022

Study: Fewer Black, Hispanic and Asian patients qualify for treatments that slow Alzheimer's progression

The development of anti-amyloid monoclonal antibodies that may slow the progression of Alzheimer's disease by breaking down amyloid plaques, a hallmark of the disease, has brought fresh hope to aging populations and the doctors who treat them.

3 Oct 2022

New algorithm may help predict the risk of Alzheimer's dementia

When people participate in studies of aging, they often want to know what their individual risks of developing dementia from Alzheimer's disease are. Washington University researchers have developed an algorithm that can help provide them with information about what their risks may be.

30 Sep 2022

Alzheimer’s researchers highlight the need for inclusive clinical trials

Enrolling representative populations in clinical trials for Alzheimer's disease is critical for finding treatments that will be safe and effective for all patients. African Americans and Latinos are disproportionately affected by this disease yet are substantially underrepresented in trials of promising therapies. For example, an analysis of data from more than 100 clinical trials testing new treatments for Alzheimer's disease found that only 12% of participants were of any non-White race or Hispanic ethnicity.

30 Sep 2022

Study: One-third of Alzheimer’s disease family caregivers experience persistent depression symptoms

More than 60% of family caregivers of individuals with Alzheimer’s disease (AD) experienced at least mild depressive symptoms already at the time the individual with AD was diagnosed. In one third of them, depressive symptoms worsened during a five-year follow-up.

30 Sep 2022

Brain stimulation combined with nasal spray containing nanoparticles can improve stroke recovery

In a recent study, researchers from Xi'an Jiaotong-Liverpool University and other universities in China have reported that brain stimulation combined with a nose spray containing nanoparticles can improve recovery after ischemic stroke in an animal model.

29 Sep 2022

Alzheimer's Disease News and Research

Further Reading

Age plays a more important role than genetics in affecting gene expression profiles as we get older

New biosensing technology for detecting Alzheimer’s disease in the blood

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

Omega-3 levels could play a role in improving cognitive resilience in middle-aged people

Consuming more omega-3s associated with better brain health and cognition in middle age

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

Newly identified mechanism may explain why women are more vulnerable to Alzheimer's disease

Viagra and Cialis may not be suitable candidates for treating dementia, NIH DREAM study shows

Stanford researchers discover a sustainable way to produce cancer-fighting compound in the lab

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

Study: Fewer Black, Hispanic and Asian patients qualify for treatments that slow Alzheimer's progression

New algorithm may help predict the risk of Alzheimer's dementia

Alzheimer’s researchers highlight the need for inclusive clinical trials

Study: One-third of Alzheimer’s disease family caregivers experience persistent depression symptoms

Brain stimulation combined with nasal spray containing nanoparticles can improve stroke recovery

Study explores the role of air pollution on the trajectory of stroke

Bariatric surgery recipients may have an elevated risk of epilepsy, study finds

High blood pressure causes faster cognitive decline, new study finds

Cycles of fasting-mimicking diet appear to reduce signs of Alzheimer’s in mice

Scientists find new piece of the puzzle in understanding how the brains of Alzheimer's patients work

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News